CDR-Life is focused on transforming the treatment of cancer and autoimmune diseases through its innovative T cell engager (TCE) platform, M-gager®
CDR-Life is focused on transforming the treatment of cancer and autoimmune diseases through its innovative T cell engager (TCE) platform, M-gager®. The company develops highly selective immunotherapies that target both conventional tumor antigens and previously inaccessible targets, aiming to enhance therapeutic efficacy while minimizing side effects.